visiongate3d.comHealthcareFounded: 1900Funding to Date: $49.27MM
VisionGate is a clinical stage oncology pharmaceutical and diagnostics company with a focus on the early detection and treatment of lung cancer and bronchial dysplasia.
For more details on financing and valuation for VisionGate, register or login.
View Enterprise Value for VisionGate.
To read this article and more news on VisionGate, register or login.